Pharmaceutical Industry Reports Telmisartan Market Size, Share, Outlook, and Analy 点击阅读
  • 评论

Pharmaceutical Industry Reports

Telmisartan Market Size, Share, Outlook, and Analy

出版日期 / “健康与健身” / 语言—English / 8页
Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. 更多
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. 更多

“Pharmaceutical Industry Reports”的其他期刊

查看所有期刊